Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 17/11/23 → 16/11/25 |
Keywords
- Clinical trial
- IDE196-009
Clinical Trial Phase
- Phase II
(Neo)adjuvant IDE196 (darovasertib) in patients with localized ocular melanoma
- Shackleton, Mark (Primary Chief Investigator (PCI))
- Brooks, Christine (Project Manager)
Project: Research